Sabine Brookman-May, Professor of Urology at Universität München, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences, shared a post on X by Cancers MDPI, adding:
“Happy to announce the first article of the Cancers MDPI special issue on AI and biomarkers in Urologic Oncology: Computational histology AI (CHAI) biomarkers meaningfully influenced treatment decisions in 67% of NMIBC cases across 6 centers, from BCG selection to cystectomy decision.”
Quoting Cancers MDPI‘s post:
“The first publication of the Special Issue.”
Title: Impact of Computational Histology AI Biomarkers on Clinical Management Decisions in Non-Muscle Invasive Bladder Cancer: A Multi-Center Real-World Study
Authors: Vignesh T. Packiam, Saum Ghodoussipour, Badrinath R. Konety, Hamed Ahmadi, Gautum Agarwal, Lesli A. Kiedrowski, Viswesh Krishna, Anirudh Joshi, Stephen B. Williams, Armine K. Smith
Read the full article on MDPI.
More posts featuring Sabine Brookman-May on OncoDaily.
